卵巢刺激期间感染SARS-CoV-2对辅助生殖技术结局的影响
这项回顾性队列研究纳入151个卵巢刺激期间感染COVID-19的治疗周期和224个未感染对照周期,比较促性腺激素总量、刺激时长、获卵数、受精率及可用囊胚数等指标,并检测卵泡液、精液和胚胎培养液中的SARS-CoV-2 RNA。结果显示两组周期特征和实验室参数相似,所有样本均未检出SARS-CoV-2 RNA。作者认为无症状或轻症COVID-19患者可安全继续IVF治疗。
要点
- 卵巢刺激期间感染SARS-CoV-2未对IVF治疗结局产生显著影响。
- 感染组与对照组在获卵数、成熟卵率及可用囊胚总数上无显著差异。
- 卵泡液、精液及胚胎培养液中均未检出SARS-CoV-2 RNA。
核心结论
- 卵巢刺激期间急性SARS-CoV-2感染对IVF治疗结局无显著影响,且未观察到对生殖系统的风险,无症状或轻症COVID-19患者可安全继续IVF治疗。
研究设计与样本
- 回顾性队列研究,在安徽医科大学第一附属医院生殖医学中心开展,纳入151个卵巢刺激期间感染COVID-19的治疗周期和224个未感染对照周期。
主要发现
- 治疗组与对照组在受精方式、促性腺激素总剂量和卵巢刺激时长等周期特征上相似。
- 每周期平均获卵数及胞浆内单精子注射周期的成熟卵母细胞率相当。
- 两组可用囊胚总数无显著差异。
- 46份卵泡液、38份精液和78份胚胎培养液样本中均未检出SARS-CoV-2 RNA。
关键数值与推荐
- 共检测46份卵泡液、38份精液和78份胚胎培养液样本的SARS-CoV-2 RNA,均未检出。
临床怎么用
- 作者认为无症状或轻症COVID-19患者可安全继续IVF治疗。
- 未来需研究COVID-19对生育力和生殖结局的长期影响。
局限性
- 未来需研究COVID-19对生育力和生殖结局的长期影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Does severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection during ovarian stimulation affect assisted reproductive technology outcomes? DESIGN: This retrospective cohort study conducted at the Reproductive Medicine Centre of The First Affiliated Hospital of Anhui Medical University aimed to assess the effects of acute SARS-CoV-2 infection during IVF on treatment outcomes and the reproductive system. The study included 151 treatment cycles involving couples with coronavirus disease 2019 (COVID-19) during ovarian stimulation, along with 224 cycles of non-infected couples as a control group. Clinical characteristics and laboratory parameters were analysed, including total gonadotrophin dosage, duration of ovarian stimulation, number of oocytes retrieved, fertilization method, fertilization rate, and number of blastocyst embryos available. Forty-six follicular fluid samples, 38 semen samples and 78 embryo culture medium samples from patients with COVID-19 were tested for SARS-CoV-2 RNA using reverse transcription polymerase chain reaction assay. RESULTS: The treatment and control groups showed similar cycle characteristics, including fertilization method, total gonadotrophin dosage and duration of ovarian stimulation. The mean number of oocytes retrieved per cycle and rate of mature oocytes in intracytoplasmic sperm injection cycles were comparable. No significant difference was observed in the total number of blastocyst embryos available between the groups. Furthermore, no SARS-CoV-2 RNA was detected in any of the samples of patients with COVID-19. CONCLUSIONS: In conclusion, acute SARS-CoV-2 infection during ovarian stimulation does not have a significant impact on IVF treatment outcomes. Additionally, no risk to the reproductive system was observed in patients infected with SARS-CoV-2. Therefore, individuals with asymptomatic or mild COVID-19 can safely continue IVF treatment. Future research is needed to investigate the long-term effects of COVID-19 on fertility and reproductive outcomes.
引用
- Yang T, Wu L, Peng J, et al. Effects of SARS-CoV-2 infection during ovarian stimulation on ART outcomes. Reprod Biomed Online. 2023. PMID: 38030535. doi:10.1016/j.rbmo.2023.103422
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。